Still hungry in week 2 of Mounjaro — is that normal?

The myth: hunger at week 2 means Mounjaro isn't working

This is probably the most common misreading of early treatment, and it's understandable. You've read about people losing significant weight, you expected something to feel different by now, and your appetite hasn't changed much. The conclusion feels obvious: the medicine isn't doing its job.

In reality, the 2.5mg starting dose was never intended to suppress hunger. It exists for one reason, to reduce the chance of nausea, vomiting and other gastrointestinal side effects that can occur when tirzepatide is introduced at a higher dose. Your prescriber isn't holding back a better version; they're following the licensed titration schedule because the evidence shows it's the safest way to reach the doses where the real appetite effect lives. The full Mounjaro overview explains how that schedule works from the beginning.

A question our prescribers hear most weeks goes something like this: "I'm on week 2 and I'm not less hungry at all, should I just stop?" The honest answer is that stopping at 2.5mg tells you almost nothing about how tirzepatide will affect you at 5mg or above.

What tirzepatide is actually doing in weeks 1 and 2

Tirzepatide is a dual GIP and GLP-1 receptor agonist, the only medicine of its kind licensed in the UK for weight management. It works on two gut-hormone pathways simultaneously, slowing how quickly the stomach empties and gradually recalibrating hunger signals in the brain. That recalibration is not instant. The medicine needs to reach and maintain a therapeutic concentration in your system, which is why the titration schedule exists and why effects accumulate with each dose step.

At week 2, many people notice subtle changes, food feels slightly less urgent, portions that used to feel small are more satisfying, or the urge to snack between meals is a little quieter. Others notice nothing at all. Both experiences are consistent with being on the starter dose. The timeline for Mounjaro's effects covers what most people experience at each phase, which may help set a more realistic frame.

According to the NHS's patient information for tirzepatide, common early side effects are mostly gastrointestinal, and the body typically adjusts within a few weeks. Appetite suppression is a therapeutic effect, not a side effect, it follows a different timeline. [NHS: tirzepatide patient information]

What usually changes after the first dose increase

Most people find that weeks 5 to 8 (after moving to 5mg) feel meaningfully different from weeks 1 to 4. Appetite tends to drop more noticeably, portion sizes become easier to manage without effort, and the background noise of hunger between meals quietens. This is the phase the clinical trials were measuring when they reported the weight-loss results you've likely seen.

The SURMOUNT-1 trial, involving 2,539 adults treated over 72 weeks, reported average body-weight reductions of around 20–21% at the 15mg maintenance dose. [SURMOUNT-1, New England Journal of Medicine] Those results were not achieved at 2.5mg. They were the cumulative outcome of the full titration journey, so week 2 is simply not the moment to judge.

If hunger remains unchanged or worsens even after dose increases, that is a different conversation worth having with your prescriber. You can read more about that scenario on our page about Mounjaro not working if you're still hungry.

Practical things that help during weeks 1 and 2

Because appetite suppression is limited at this stage, the choices you make now still matter quite a bit. Prioritising protein at each meal (eggs, fish, lean meat, legumes) helps you feel fuller for longer and also protects muscle while your body adjusts. Keeping well hydrated is useful too, partly because thirst is easy to confuse with hunger, and partly because adequate fluid supports the GI system during the adjustment period.

Eating slowly matters more now than it might later, when the medicine itself slows gastric emptying further. Giving your body time to register fullness before you finish a plate is one of the most practical things you can do in early weeks.

If cost has been on your mind while reading about treatment (which is a fair question given that Eli Lilly raised UK list prices significantly from September 2025) our treatment overview explains the options available through a regulated private route.

Week 3 brings some people their first real shift in hunger, and others have to wait a little longer. If you're curious about what week 3 tends to look like, that page covers it in detail. And if you're still on 2.5mg and hungry after week 2 specifically, this follow-up goes deeper into what to do next.

If you haven't started yet and want a prescriber to look at your situation properly, you can speak to our prescribers through a free consultation, reviewed the same day by a real clinician, not a queue and a bot.